Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity
Authors:
- 7 September 2022
- Vol. 163 (1) , 204-215
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- National Institutes of Health (K01DK116917, P01 HL108800, R01ES027595, HL105333, HL 122596, HL 124021, R01-HL134168, R01 HL136603, R01 HL142720, R01-HL142983, R01-HL143227, R01-HL155955-01A1, S10OD020025, U54-AG065141)
- American Heart Association (18EIA33900027)
- CHEST Foundation
This publication has 42 references indexed in Scilit:
- Blocking Macrophage Leukotriene B 4 Prevents Endothelial Injury and Reverses Pulmonary HypertensionScience Translational Medicine, 2013
- Prostaglandin F2α facilitates collagen synthesis in cardiac fibroblasts via an F-prostanoid receptor/protein kinase C/Rho kinase pathway independent of transforming growth factor β1The International Journal of Biochemistry & Cell Biology, 2012
- The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAHAnnals of the Rheumatic Diseases, 2012
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: Potential new clinical implications for an old hormoneCritical Care Medicine, 2008
- Hyponatremia Predicts Right Heart Failure and Poor Survival in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Oxidative Injury Induced Cyclooxygenase Activation in Experimental HepatotoxicityBiochemical and Biophysical Research Communications, 1999
- Pharmacodynamic profile of prostacyclinThe American Journal of Cardiology, 1995
- Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions.Hypertension, 1990